Methyldopa injection contraindications

Jump to navigation Jump to search
Methyldopa
Methyldopa tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
Methyldopa injection® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings
Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Methyldopa
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

CONTRAINDICATIONS

Methyldopate hydrochloride is contraindicated in patients:

- with active hepatic disease, such as acute hepatitis and active cirrhosis.

- with liver disorders previously associated with methyldopa therapy (see WARNINGS).

- with hypersensitivity to any component of this product, including sulfites (see WARNINGS).

- on therapy with monoamine oxidase (MAO) inhibitors.[1]



References

  1. "METHYLDOPATE HYDROCHLORIDE INJECTION, SOLUTION [AMERICAN REGENT, INC.]". Retrieved 10 March 2014.